News Center

The ISPOR Europe 2022 conference theme—Collaborating Across Borders: Building & Using Evidence to Enable Access—is a “thread” that is woven throughout the conference's many sessions to bring a fresh and holistic view of collaborating across borders for building and using evidence to enable access. The conference theme is especially timely, as the new Health Technology Assessment (HTA) Regulation in the European Union has spurred conversations about how different countries, regions, or even cities, can work together in a variety of outcomes research methods.

Check the News Center frequently as the conference begins. News will be posted as it is published before, during, and after the conference.

Conference News

Inside the Third Plenary: A Multistakeholder Perspective on Evidence Generation and Integrating Data [The Evidence Base]

ISPOR Europe 2022 Daily Round-Ups: Day 3 [The Evidence Base]

PODCAST: What Are the Hot Topics in Market Access Based on ISPOR Europe 2022 [MAP]

Uncertainty in Approaching Living HTA Creates “Missed Opportunities” [Navlin Daily News]

Inside the Second Plenary: Understanding What Is Important to Patients [The Evidence Base]

ISPOR Europe 2022 Daily Round-Ups: Day 2 [The Evidence Base]

Real-World Patient-Centered Research: Is It Possible Across Countries [Healthcare Economist]

UK, France, U.S. & Germany “Continue to Dominate” RWE Use in HTA [Navlin Daily News]

Inside the First Plenary: Collaboration, Evidence Generation, and Equity [The Evidence Base]

Heterogeneity Between European and US Reimbursement Decisions for Gene Therapies [Navlin Daily News]

“It’s the Evidence, Stupid” [Healthcare Economist]

Plenary Session 1 – The Convergence of HTA and Regulation: A New HTA Reality and Collaboration with Regulatory Agencies [Remap]

ISPOR Europe 2022 Daily Round-Ups: Day 1 [The Evidence Base]

EMA Director Confident in “Concrete Steps” Toward Joint HTA [Navlin Daily News]

ISPOR Europe 2022: Making the Most of This Year’s Conference [The Evidence Base]

ISPOR Europe 2022: Editor’s Pick of Sessions to Look Out For [The Evidence Base]

Poster and Session Presentations News

ISPOR Europe 2022 Recap: Focused on Patients, Outcomes, and Study Approaches

IRRAS AB publishes Interim Report for the period January to September 2022

Implantica Presents RefluxStop's Health Economic Impact at ISPOR Europe 2022

Cost-Effectiveness of CERAMENT® G in the United States Presented at ISPOR Conference

Pear Therapeutics Presents Real-World Data Showing Reduction in Healthcare Resource Utilization and Associated Costs in Adults Using Somryst® at ISPOR Europe

Verana Health to Present Findings of Studies Using American Academy of Ophthalmology IRIS® Registry Data to Advance Insights into Real World Outcomes in Treating AMDights into Real World Outcomes in Treating AMDrope

MY01 Announces Its Inclusion in Economic Model Data Presented at ISPOR Europe 2022

Flatiron Health Announces Research to be Presented at ISPOR Europe 2022

Peek Behind the Poster: A Value Based Budget Impact Model For Dronedarone

Axtria Presents Two HEOR/RWE Studies at ISPOR Europe 2022

GlobalData Poster Presentations at ISPOR Europe in Vienna  

Amplity Health Announces Two Posters Accepted at the ISPOR Europe 2022 Conference

Meet the Open Health Innovators Behind the Science

Axtria Presents Two HEOR/RWE Studies At ISPOR Europe 2022

Analysis Group HEOR Consultants Present at ISPOR Europe 2022

RTI Health Solutions at ISPOR Europe 2022

Cytel at ISPOR Europe: Top Presenter of Issue Panels and Workshops

QM Contributing to Health Economics & Outcomes Research at ISPOR Europe 2022

ISPOR Europe 2022:  PRMA Consulting - from pipeline assets to patient access

Genesis Research at ISPOR Europe 2022

Photo Gallery

Other News

ISPOR News

Thank You to ISPOR Europe 2022 Media Partners:

Thank you to ISPOR Europe 2022's Media Partners: The Evidence Base and the Journal of Medical Economics, as well as all the media outlets who are reporting on the conference.

Disclaimer:

The reporting on ISPOR Europe 2022 from external news sources reflects the views of the authors/media outlets and is not endorsed by ISPOR.